LONDON, Sept 20 (Reuters) - Emma Walmsley, GlaxoSmithKline's
incoming CEO, breaks the mould as the first woman to
lead a top global drugmaker and stands out among Big Pharma
bosses as a consumer brands guru rather than a prescription
medicines expert.
Read more
No comments:
Post a Comment